Skip to content

Public FDA record

Z-2200-2010: International Technidyne Corporation (ITC) directCheck Whole Blood Quality Controls Plasma, Coagulation C

Recall record Z-2200-2010 for International Technidyne Corp.. View source facts, labeled dates, and the original FDA record.

FDA identifier
Z-2200-2010
Company in FDA record
International Technidyne Corp.
FDA classification date
Aug 10, 2010
First observed by MedTech Watch
Nov 16, 2026
Latest observed content change
Nov 20, 2026
Recall classification
Unknown — no matched enforcement classification

Reason stated in the source

The package insert for the directCheck Microcoagulation Quality Control contains an incorrect acceptable performance range regarding ACT-LR cuvettes

Source facts

Action
ITC sent Urgent Medical Device Correction letters on June 25, 2010 by Federal Express to hospital Risk Managers and Lab Directors, Clinical Laboratory Manager or Point-of-Care Coordinators.
Initiated
2010-06-25
Root cause
Nonconforming Material/Component
Terminated
2010-09-23
Distribution
Nationwide and one customer in Belgium.
Recall number
Z-2200-2010
Recall status
Terminated
CDRH record ID
92697
FDA classified
2010-08-10
Recall event number
56117

Source facts and excerpts are reproduced for research. Dates retain their source meanings. “First observed” describes collection, not FDA publication or product launch.

Recall classification is supplied only when the recall number matches an enforcement record. Recall class and device class are different fields. Several recall records may belong to one recall event.

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 22, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗